News APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF) Staff September 11, 2023 Iframe sync Post navigation Previous: Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of DirectorsNext: Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse More Stories Diagnostics Fitness News Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship Staff December 22, 2025 Cancer Diagnostics DNA News Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach Staff December 22, 2025 EHR Healthcare News KLAS Report Shows Strong Early Results for TrustCommerce Cloud Payments Staff December 22, 2025
